Christos Sachpekidis Selected Research

Christos Sachpekidis Research Topics

Disease

22	Melanoma (Melanoma, Malignant) 10/2023 - 03/2015
18	Neoplasms (Cancer) 05/2023 - 01/2013
16	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 11/2016
6	Multiple Myeloma 05/2020 - 07/2014
5	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2015
3	Disease Progression 05/2021 - 09/2017
3	Sarcoma (Soft Tissue Sarcoma) 06/2019 - 08/2016
2	Bone Diseases (Bone Disease) 05/2020 - 12/2019
2	Colitis 01/2019 - 01/2019
1	Metabolic Diseases (Metabolic Disease) 01/2023
1	Smoldering Multiple Myeloma 04/2021
1	Chromosome Aberrations (Chromosome Abnormalities) 05/2020
1	Hemarthrosis 04/2020
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2020
1	Hyperthyroidism 01/2020
1	Lymphatic Metastasis 01/2020
1	Malignant Pleural Effusion 10/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 09/2019
1	Hematologic Neoplasms (Hematological Malignancy) 09/2019
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2019
1	Lymphadenopathy 02/2019
1	Hypophysitis 01/2019
1	Hepatitis 01/2019
1	Arthritis (Polyarthritis) 01/2019
1	Papillary Carcinoma 08/2017
1	Thyroglossal Cyst 08/2017
1	Angiomyolipoma 05/2017
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2017
1	Hemorrhage 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2015
1	Aggressive Fibromatosis (Desmoid) 01/2013
1	Colorectal Neoplasms (Colorectal Cancer) 01/2013

Drug/Important Bio-Agent (IBA)

18	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 09/2021 - 03/2015
15	IpilimumabIBA 10/2023 - 03/2015
9	Immune Checkpoint InhibitorsIBA 10/2023 - 04/2020
6	gallium 68 PSMA-11IBA 01/2021 - 11/2016
5	NivolumabIBA 10/2023 - 10/2018
4	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2013
4	pembrolizumabIBA 10/2021 - 02/2016
4	LigandsIBA 03/2021 - 10/2019
4	AntigensIBA 01/2021 - 01/2019
3	Glucose (Dextrose)FDA LinkGeneric 09/2021 - 01/2013
3	Monoclonal AntibodiesIBA 09/2019 - 12/2016
2	RadiopharmaceuticalsIBA 05/2023 - 12/2019
2	Sodium Fluoride (Ossin)FDA Link 05/2020 - 07/2014
2	pazopanib FDA Link 06/2019 - 05/2019
2	VemurafenibIBA 01/2019 - 09/2017
2	Fluorine-18IBA 01/2015 - 07/2014
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Glycoproteins (Glycoprotein)IBA 03/2021
1	IntegrinsIBA 03/2021
1	Programmed Cell Death 1 ReceptorIBA 03/2021
1	DiureticsIBA 01/2021
1	Osmium TetroxideIBA 04/2020
1	SteroidsIBA 04/2020
1	Choline (Choline Chloride)IBA 02/2020
1	Codon (Codons)IBA 01/2020
1	N 30IBA 01/2020
1	Rituximab (Mabthera)FDA Link 01/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	Furosemide (Lasix)FDA LinkGeneric 01/2020
1	Vincristine (Oncovin)FDA LinkGeneric 01/2020
1	IodineIBA 01/2020
1	Prednisolone (Predate)FDA LinkGeneric 01/2020
1	Indicators and Reagents (Reagents)IBA 12/2019
1	ibritumomab tiuxetan (Zevalin)FDA Link 09/2019
1	Radioisotopes (Radionuclides)IBA 09/2019
1	tositumomab I-131 (Bexxar)FDA Link 09/2019
1	Radium-223IBA 05/2019
1	CalciumIBA 05/2019
1	Gastrin-Releasing PeptideIBA 01/2019
1	Bombesin Receptors (Bombesin Receptor)IBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 11/2018
1	Lenalidomide (CC 5013)FDA Link 12/2017
1	elotuzumabIBA 12/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2017
1	FluorineIBA 05/2017
1	MTOR InhibitorsIBA 05/2017
1	TOR Serine-Threonine KinasesIBA 05/2017
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	Imatinib Mesylate (Gleevec)FDA Link 01/2013

Therapy/Procedure

22	Therapeutics 10/2021 - 01/2013
10	Immunotherapy 10/2023 - 01/2018
3	Stem Cell Transplantation 05/2020 - 01/2017
1	Precision Medicine 01/2024
1	Synovectomy 04/2020
1	Injections 04/2020
1	Pleurodesis 10/2019
1	Radioimmunotherapy 09/2019
1	Castration 05/2019
1	Prostatectomy (Retropubic Prostatectomy) 05/2017
1	Drug Therapy (Chemotherapy) 01/2017
1	Aftercare (After-Treatment) 12/2016
1	Radiotherapy 01/2015